Singapore markets close in 2 hours 40 minutes

MacroGenics, Inc. (MGNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.74-1.06 (-3.81%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 51.45B
Enterprise value 31.24B
Trailing P/E N/A
Forward P/E 1-11.24
PEG Ratio (5 yr expected) 10.03
Price/sales (ttm)18.57
Price/book (mrq)5.76
Enterprise value/revenue 315.97
Enterprise value/EBITDA 6-7.84

Trading information

Stock price history

Beta (5Y monthly) 2.72
52-week change 393.19%
S&P500 52-week change 317.36%
52-week high 332.18
52-week low 34.04
50-day moving average 327.88
200-day moving average 316.41

Share statistics

Avg vol (3-month) 31.43M
Avg vol (10-day) 3364.28k
Shares outstanding 554.09M
Float 52.46M
% held by insiders 17.42%
% held by institutions 194.18%
Shares short (30 Jul 2020) 44.16M
Short ratio (30 Jul 2020) 47.47
Short % of float (30 Jul 2020) 48.94%
Short % of shares outstanding (30 Jul 2020) 47.70%
Shares short (prior month 29 Jun 2020) 44.67M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Jun 2020


Profit margin -213.99%
Operating margin (ttm)-217.48%

Management effectiveness

Return on assets (ttm)-29.76%
Return on equity (ttm)-61.46%

Income statement

Revenue (ttm)77.87M
Revenue per share (ttm)1.58
Quarterly revenue growth (yoy)91.20%
Gross profit (ttm)-131.12M
EBITDA -158.58M
Net income avi to common (ttm)-166.64M
Diluted EPS (ttm)-3.38
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)232.8M
Total cash per share (mrq)4.3
Total debt (mrq)29.04M
Total debt/equity (mrq)11.72
Current ratio (mrq)5.67
Book value per share (mrq)4.64

Cash flow statement

Operating cash flow (ttm)-136.12M
Levered free cash flow (ttm)-93.8M